IDEAS home Printed from https://ideas.repec.org/f/psh344.html
   My authors  Follow this author

Ya-Chen Tina Shih

Personal Details

First Name:Ya-Chen
Middle Name:Tina
Last Name:Shih
Suffix:
RePEc Short-ID:psh344
[This author has chosen not to make the email address public]

Affiliation

University of Texas M.D. Anderson Cancer Center

http://www.mdanderson.org
USA, Houston

Research output

as
Jump to: Articles

Articles

  1. Yoon Grace & Jiang Wenxin & Liu Lei & Shih Ya-Chen Tina, 2020. "Simple Quasi-Bayes Approach for Modeling Mean Medical Costs," The International Journal of Biostatistics, De Gruyter, vol. 16(1), pages 1-10, May.
  2. Ya-Chen Tina Shih & Ying Xu & Chun-Ru Chien & Bumyang Kim & Yu Shen & Liang Li & Daniel M. Geynisman, 2019. "Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II—An Updated Analysis of SEER-Medicare Data," PharmacoEconomics, Springer, vol. 37(12), pages 1495-1507, December.
  3. Chun-Ru Chien & Daniel M. Geynisman & Bumyang Kim & Ying Xu & Ya-Chen Tina Shih, 2019. "Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review," PharmacoEconomics, Springer, vol. 37(3), pages 301-331, March.
  4. Liang Li & Chih-Hsien Wu & Jing Ning & Xuelin Huang & Ya-Chen Tina Shih & Yu Shen, 2018. "Semiparametric Estimation of Longitudinal Medical Cost Trajectory," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 113(522), pages 582-592, April.
  5. Chan Shen & Arvind Dasari & Dian Gu & Yiyi Chu & Shouhao Zhou & Ying Xu & Daniel Halperin & Shuangshuang Fu & James C. Yao & Ya-Chen Tina Shih, 2018. "Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors," PharmacoEconomics, Springer, vol. 36(8), pages 1005-1013, August.
  6. Ya-Chen Tina Shih & Shelley Fuld Nasso & S. Yousuf Zafar, 2018. "Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care," PharmacoEconomics, Springer, vol. 36(3), pages 259-261, March.
  7. Fabrice Smieliauskas & Hari Sharma & Connor Hurley & Jonas A. de Souza & Ya‐Chen Tina Shih, 2018. "State insurance mandates and off‐label use of chemotherapy," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 55-70, January.
  8. Daisuke Goto & Ya-Chen Tina Shih & Pascal Lecomte & Melvin Olson & Chukwukadibia Udeze & Yujin Park & C. Daniel Mullins, 2017. "Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 35(7), pages 685-695, July.
  9. Shen, Chan & Tina Shih, Ya-Chen, 2016. "Therapeutic substitutions in the midst of new technology diffusion: The case of treatment for localized prostate cancer," Social Science & Medicine, Elsevier, vol. 151(C), pages 110-120.
  10. Marcelo Coca Perraillon & Ya-Chen Tina Shih & Ronald A. Thisted, 2015. "Predicting the EQ-5D-3L Preference Index from the SF-12 Health Survey in a National US Sample," Medical Decision Making, , vol. 35(7), pages 888-901, October.
  11. Hyojung Tak & Gregory Ruhnke & Ya-Chen Shih, 2015. "The Association between Patient-Centered Attributes of Care and Patient Satisfaction," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 8(2), pages 187-197, April.
  12. Fabrice Smieliauskas & Chun-Ru Chien & Chan Shen & Daniel Geynisman & Ya-Chen Shih, 2014. "Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review," PharmacoEconomics, Springer, vol. 32(7), pages 651-680, July.
  13. Ya‐Chen Tina Shih & Ming Tai‐Seale, 2012. "Physicians' perception of demand‐induced supply in the information age: a latent class model analysis," Health Economics, John Wiley & Sons, Ltd., vol. 21(3), pages 252-269, March.
  14. Junling Wang & C. Daniel Mullins & Cyril F. Chang & Dick R. Gourley & Ya-Chen Tina Shih & William C. Cushman & Samuel Dagogo-Jack & Shelley I. White-Means, 2010. "Comparisons of changes over time in per capita health expenditures across racial and ethnic groups," International Journal of Public Policy, Inderscience Enterprises Ltd, vol. 6(3/4), pages 172-189.
  15. Liu, Lei & Strawderman, Robert L. & Cowen, Mark E. & Shih, Ya-Chen T., 2010. "A flexible two-part random effects model for correlated medical costs," Journal of Health Economics, Elsevier, vol. 29(1), pages 110-123, January.
  16. Ya-Chen Shih & Nebiyou Bekele & Ying Xu, 2007. "Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients," PharmacoEconomics, Springer, vol. 25(10), pages 843-862, October.
  17. Ya-Chen Shih & Josephine Mauskopf & Rohit Borker, 2007. "A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma," PharmacoEconomics, Springer, vol. 25(7), pages 577-590, July.
  18. Ya-Chen Shih & Lajos Pusztai, 2006. "Do Pharmacogenomic Tests Provide Value to Policy Makers?," PharmacoEconomics, Springer, vol. 24(12), pages 1173-1177, December.
  19. Ya-Chen Tina Shih & Shu Han & Scott B. Cantor, 2005. "Impact of Generic Drug Entry on Cost-Effectiveness Analysis," Medical Decision Making, , vol. 25(1), pages 71-80, January.
  20. Sleath, Betsy & Tina Shih, Ya-Chen, 2003. "Sociological influences on antidepressant prescribing," Social Science & Medicine, Elsevier, vol. 56(6), pages 1335-1344, March.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Articles

  1. Chun-Ru Chien & Daniel M. Geynisman & Bumyang Kim & Ying Xu & Ya-Chen Tina Shih, 2019. "Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review," PharmacoEconomics, Springer, vol. 37(3), pages 301-331, March.

    Cited by:

    1. Chia-Chin Li & Ying-Chun Lin & Ji-An Liang & K. S. Clifford Chao & Te-Chun Hsia & Chun-Ru Chien, 2023. "Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review," IJERPH, MDPI, vol. 20(6), pages 1-10, March.

  2. Liang Li & Chih-Hsien Wu & Jing Ning & Xuelin Huang & Ya-Chen Tina Shih & Yu Shen, 2018. "Semiparametric Estimation of Longitudinal Medical Cost Trajectory," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 113(522), pages 582-592, April.

    Cited by:

    1. Lih-Wen Mau & Jaime M. Preussler & Linda J. Burns & Susan Leppke & Navneet S. Majhail & Christa L. Meyer & Tatenda Mupfudze & Wael Saber & Patricia Steinert & David J. Vanness, 2020. "Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach," PharmacoEconomics, Springer, vol. 38(5), pages 515-526, May.

  3. Ya-Chen Tina Shih & Shelley Fuld Nasso & S. Yousuf Zafar, 2018. "Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care," PharmacoEconomics, Springer, vol. 36(3), pages 259-261, March.

    Cited by:

    1. Christine Leopold & Carina Araujo-Lane & Carol Rosenberg & Melissa Gilkey & Anita K. Wagner, 2020. "Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program," PharmacoEconomics - Open, Springer, vol. 4(2), pages 389-392, June.

  4. Daisuke Goto & Ya-Chen Tina Shih & Pascal Lecomte & Melvin Olson & Chukwukadibia Udeze & Yujin Park & C. Daniel Mullins, 2017. "Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 35(7), pages 685-695, July.

    Cited by:

    1. Gilbert, Patrick & Laporte, Marie-Eve, 2022. "War and peace in hospitals: Humans, objects and paradoxes," Journal of Business Research, Elsevier, vol. 141(C), pages 253-263.
    2. Patrick Gilbert & Marie-Eve Laporte, 2022. "L’orientation patient à l’hôpital public : un dispositif marketing comme compromis entre mondes," Post-Print halshs-03737724, HAL.

  5. Shen, Chan & Tina Shih, Ya-Chen, 2016. "Therapeutic substitutions in the midst of new technology diffusion: The case of treatment for localized prostate cancer," Social Science & Medicine, Elsevier, vol. 151(C), pages 110-120.

    Cited by:

    1. Gagliardi, Dimitri & Ramlogan, Ronnie & Navarra, Pierluigi & Dello Russo, Cinzia, 2018. "Diffusion of complementary evolving pharmaceutical innovations: The case of Abacavir and its pharmacogenetic companion diagnostic in Italy," Technological Forecasting and Social Change, Elsevier, vol. 134(C), pages 223-233.
    2. Horn, Danea & Sacarny, Adam & Zhou, Annetta, 2022. "Technology adoption and market allocation: The case of robotic surgery," Journal of Health Economics, Elsevier, vol. 86(C).

  6. Marcelo Coca Perraillon & Ya-Chen Tina Shih & Ronald A. Thisted, 2015. "Predicting the EQ-5D-3L Preference Index from the SF-12 Health Survey in a National US Sample," Medical Decision Making, , vol. 35(7), pages 888-901, October.

    Cited by:

    1. Fan Yang & Carlos K. H. Wong & Nan Luo & James Piercy & Rebecca Moon & James Jackson, 2019. "Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1195-1206, November.

  7. Ya‐Chen Tina Shih & Ming Tai‐Seale, 2012. "Physicians' perception of demand‐induced supply in the information age: a latent class model analysis," Health Economics, John Wiley & Sons, Ltd., vol. 21(3), pages 252-269, March.

    Cited by:

    1. Alexander Ahammer & Thomas Schober, 2018. "Exploring Variations in Healthcare Expenditures - What is the Role of Practice Styles?," CDL Aging, Health, Labor working papers 2018-04, The Christian Doppler (CD) Laboratory Aging, Health, and the Labor Market, Johannes Kepler University Linz, Austria.
    2. Christian Schmid, 2015. "Consumer Health Information and the Demand for Physician Visits," Health Economics, John Wiley & Sons, Ltd., vol. 24(12), pages 1619-1631, December.
    3. Anita Charlesworth & Sarah Lafond, 2017. "Shifting from Undersupply to Oversupply: Does NHS Workforce Planning Need a Paradigm Shift?," Economic Affairs, Wiley Blackwell, vol. 37(1), pages 36-52, February.
    4. Moran, Patrick S. & Daly, Deirdre & Wuytack, Francesca & Carroll, Margaret & Turner, Michael & Normand, Charles & Begley, Cecily, 2020. "Predictors of choice of public and private maternity care among nulliparous women in Ireland, and implications for maternity care and birth experience," Health Policy, Elsevier, vol. 124(5), pages 556-562.
    5. Hiroaki Suenaga & Maria Rosalía Vicente, 2022. "Online and offline health information seeking and the demand for physician services," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(3), pages 337-356, April.

  8. Liu, Lei & Strawderman, Robert L. & Cowen, Mark E. & Shih, Ya-Chen T., 2010. "A flexible two-part random effects model for correlated medical costs," Journal of Health Economics, Elsevier, vol. 29(1), pages 110-123, January.

    Cited by:

    1. Shi, Peng & Feng, Xiaoping & Ivantsova, Anastasia, 2015. "Dependent frequency–severity modeling of insurance claims," Insurance: Mathematics and Economics, Elsevier, vol. 64(C), pages 417-428.
    2. Qianhong Lu & Xiaoqing Gan & Zhensheng Chen, 2023. "The Impact of Medical Insurance Payment Policy Reform on Medical Cost and Medical Burden in China," Sustainability, MDPI, vol. 15(3), pages 1-18, January.
    3. Y. T. Hwang & C. H. Huang & W. L. Yeh & Y. D. Shen, 2017. "The weighted general linear model for longitudinal medical cost data – an application in colorectal cancer," Journal of Applied Statistics, Taylor & Francis Journals, vol. 44(2), pages 288-307, January.
    4. Mohadeseh Shojaei Shahrokhabadi & (Din) Ding-Geng Chen & Sayed Jamal Mirkamali & Anoshirvan Kazemnejad & Farid Zayeri, 2021. "Marginalized Two-Part Joint Modeling of Longitudinal Semi-Continuous Responses and Survival Data: With Application to Medical Costs," Mathematics, MDPI, vol. 9(20), pages 1-20, October.
    5. Liu, Yue & Liu, Lei & Zhou, Jianhui, 2015. "Joint latent class model of survival and longitudinal data: An application to CPCRA study," Computational Statistics & Data Analysis, Elsevier, vol. 91(C), pages 40-50.
    6. Arnab Mukherji & Satrajit Roychowdhury & Pulak Ghosh & Sarah Brown, 2012. "Estimating Healthcare Demand for an Aging Population: A Flexible and Robust Bayesian Joint Model," Working Papers 2012027, The University of Sheffield, Department of Economics.
    7. Wouterse, Bram & Huisman, Martijn & Meijboom, Bert R. & Deeg, Dorly J.H. & Polder, Johan J., 2013. "Modeling the relationship between health and health care expenditures using a latent Markov model," Journal of Health Economics, Elsevier, vol. 32(2), pages 423-439.
    8. Beom Seuk Hwang & Zhen Chen & Germaine M. Buck Louis & Paul S. Albert, 2019. "A Bayesian multi‐dimensional couple‐based latent risk model with an application to infertility," Biometrics, The International Biometric Society, vol. 75(1), pages 315-325, March.
    9. Matthew L. Maciejewski & Chuan‐Fen Liu & Andrew L. Kavee & Maren K. Olsen, 2012. "How Price Responsive Is The Demand For Specialty Care?," Health Economics, John Wiley & Sons, Ltd., vol. 21(8), pages 902-912, August.
    10. Haitao Chai & Hongmei Jiang & Lu Lin & Lei Liu, 2018. "A marginalized two-part Beta regression model for microbiome compositional data," PLOS Computational Biology, Public Library of Science, vol. 14(7), pages 1-16, July.
    11. Bram Wouterse & Bert R. Meijboom & Johan J. Polder, 2011. "The relationship between baseline health and longitudinal costs of hospital use," Health Economics, John Wiley & Sons, Ltd., vol. 20(8), pages 985-1008, August.
    12. Shelley A. Blozis & Ricardo Villarreal & Sweta Thota & Nicholas Imparato, 2019. "Using a two-part mixed-effects model for understanding daily, individual-level media behavior," Journal of Marketing Analytics, Palgrave Macmillan, vol. 7(4), pages 234-250, December.

  9. Ya-Chen Shih & Nebiyou Bekele & Ying Xu, 2007. "Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients," PharmacoEconomics, Springer, vol. 25(10), pages 843-862, October.

    Cited by:

    1. Mohamed El Alili & Johanna M. van Dongen & Jonas L. Esser & Martijn W. Heymans & Maurits W. van Tulder & Judith E. Bosmans, 2022. "A scoping review of statistical methods for trial‐based economic evaluations: The current state of play," Health Economics, John Wiley & Sons, Ltd., vol. 31(12), pages 2680-2699, December.

  10. Ya-Chen Tina Shih & Shu Han & Scott B. Cantor, 2005. "Impact of Generic Drug Entry on Cost-Effectiveness Analysis," Medical Decision Making, , vol. 25(1), pages 71-80, January.

    Cited by:

    1. Martin Hoyle, 2011. "Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 29(1), pages 1-15, January.
    2. Ya-Chen Shih & Nebiyou Bekele & Ying Xu, 2007. "Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients," PharmacoEconomics, Springer, vol. 25(10), pages 843-862, October.
    3. Srivatsa Srinivas, S. & Marathe, Rahul R., 2021. "Averting adverse selection: The Government of India's scheme to distribute affordable medicines," Socio-Economic Planning Sciences, Elsevier, vol. 78(C).
    4. James F. O’Mahony & Joost van Rosmalen & Ann G. Zauber & Marjolein van Ballegooijen, 2013. "Multicohort Models in Cost-Effectiveness Analysis," Medical Decision Making, , vol. 33(3), pages 407-414, April.

  11. Sleath, Betsy & Tina Shih, Ya-Chen, 2003. "Sociological influences on antidepressant prescribing," Social Science & Medicine, Elsevier, vol. 56(6), pages 1335-1344, March.

    Cited by:

    1. Katolik, Aleksandra & Oswald, Andrew J., 2017. "Antidepressants for Economists and Business-School Researchers: An Introduction and Review," IZA Discussion Papers 10959, Institute of Labor Economics (IZA).
    2. Blanchflower, David G. & Oswald, Andrew J., 2011. "Antidepressants and Age," IZA Discussion Papers 5785, Institute of Labor Economics (IZA).
    3. Blanchflower, David G. & Oswald, Andrew J., 2016. "Antidepressants and age: A new form of evidence for U-shaped well-being through life," Journal of Economic Behavior & Organization, Elsevier, vol. 127(C), pages 46-58.
    4. Katolik, Aleksandra & Oswald, Andrew J., 2017. "Antidepressants for Economists and Business-School Researchers: An Introduction and Review," CAGE Online Working Paper Series 338, Competitive Advantage in the Global Economy (CAGE).
    5. Blanchflower, David G; Oswald, Andrew, 2011. "Antidepressants and Age," CAGE Online Working Paper Series 44, Competitive Advantage in the Global Economy (CAGE).
    6. Lin, Shu-Jou & Jan, Kuan-An & Kao, Jen-Tse, 2011. "Colleague interactions and new drug prescribing behavior: The case of the initial prescription of antidepressants in Taiwanese medical centers," Social Science & Medicine, Elsevier, vol. 73(8), pages 1208-1213.
    7. Soma Ganesan & Hiram Mok & Mario McKenna, 2011. "Perception of Mental Illness: Preliminary Exploratory Research At a Cross-Cultural Outpatient Psychiatric Clinic," International Journal of Social Psychiatry, , vol. 57(1), pages 81-89, January.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Ya-Chen Tina Shih should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.